Advertisement
Screener

Dolby Laboratories, Inc. (DLB) Cash and securities

Dolby Laboratories, Inc. (DLB) Cash and securities

  • Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-26..
  • Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-26..

Cash and securities

Overview →

Financial period ending 2026-06-26; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Total cash · latest quarter (USD)(m)Cash and cash equivalents plus current marketable securities. Period ending 2026-06-26.

Calculation unavailable: missing inputs remain (m).

Cash per share · latest quarter(m)Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-26.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Cash and equivalents669.39M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Cash and current securities(m)Cash and Cash Equivalents, at Carrying Value
Quarter-end shares(m)

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingTotal cashCash per shareCash and equivalents (USD)Short-term securities (USD)Quarter-end shares (shares)
2026-06-26(m)(m)$669.39M(m)(m)
2026-03-27(m)(m)$594.28M(m)(m)
2025-12-26(m)(m)$643.85M(m)(m)
2025-09-26(m)(m)$701.89M(m)(m)
2025-06-27(m)(m)$698.57M(m)(m)
2025-03-28(m)(m)$626.55M(m)(m)
2024-12-27(m)(m)$520.82M(m)(m)
2024-09-27(m)(m)$482.05M(m)(m)
2024-06-28(m)(m)$741.64M(m)(m)
2024-03-29(m)(m)$709.53M(m)(m)
2023-12-29(m)(m)$656.82M(m)(m)
2023-09-29(m)(m)$745.36M(m)(m)
2023-06-30(m)(m)$765.08M(m)(m)
2023-03-31(m)(m)$688.44M(m)(m)
2022-12-30(m)(m)$626.16M(m)(m)
2022-09-30(m)(m)$620.13M(m)(m)
2022-07-01(m)(m)$858.90M(m)(m)
2022-04-01(m)(m)$900.39M(m)(m)
2021-12-31(m)(m)$1.06B(m)(m)
2021-09-24(m)(m)$1.23B(m)(m)
2021-06-25(m)(m)$1.22B(m)(m)
2021-03-26(m)(m)$1.10B(m)(m)
2020-12-25(m)(m)$1.11B(m)(m)
2020-09-25(m)(m)$1.07B(m)(m)
2020-06-26(m)(m)$855.10M(m)(m)
2020-03-27(m)(m)$724.93M(m)(m)
2019-12-27(m)(m)$741.43M(m)(m)
2019-09-27(m)(m)$797.21M(m)(m)
2019-06-28(m)(m)$716.56M(m)(m)
2019-03-29(m)(m)$726.60M(m)(m)
2018-12-28(m)(m)$790.79M(m)(m)
2018-09-28(m)(m)$918.06M(m)(m)
2018-06-29(m)(m)$829.62M(m)(m)
2018-03-30(m)(m)$705.52M(m)(m)
2017-12-29(m)(m)$596.39M(m)(m)
2017-09-29(m)(m)$627.02M(m)(m)
2017-06-30(m)(m)$592.62M(m)(m)
2017-03-31(m)(m)$532.51M(m)(m)
2016-12-30(m)(m)$512.84M(m)(m)
2016-09-30(m)(m)$516.11M(m)(m)
2016-07-01(m)(m)$599.99M(m)(m)
2016-04-01(m)(m)$521.20M(m)(m)
2016-01-01(m)(m)$467.10M(m)(m)
2015-09-25(m)(m)$531.93M(m)(m)
2015-06-26(m)(m)$470.87M(m)(m)
2015-03-27(m)(m)$513.99M(m)(m)
2014-12-26(m)(m)$409.12M(m)(m)
2014-09-26(m)(m)$568.47M(m)(m)
2014-06-27(m)(m)$590.10M(m)(m)
2014-03-28(m)(m)$568.90M(m)(m)
2013-12-27(m)(m)$484.64M(m)(m)
2013-09-27(m)(m)$454.40M(m)(m)
2013-06-28(m)(m)$408.56M(m)(m)
2013-03-29(m)(m)$328.51M(m)(m)
2012-12-28(m)(m)$316.19M(m)(m)
2012-09-28(m)(m)$492.60M(m)(m)
2012-06-29(m)(m)$670.41M(m)(m)
2012-03-30(m)(m)$747.99M(m)(m)
2011-12-30(m)(m)$654.41M(m)(m)
2011-09-30(m)(m)$551.51M(m)(m)
2011-07-01(m)(m)$594.60M(m)(m)
2011-04-01(m)(m)$520.27M(m)(m)
2010-12-31(m)(m)$433.64M(m)(m)
2010-09-24(m)(m)$545.86M(m)(m)
2010-06-25(m)(m)$519.10M(m)(m)
2010-03-26(m)(m)$417.35M(m)(m)
2009-12-25(m)(m)$406.24M(m)(m)
2009-09-25(m)(m)$451.68M(m)(m)
2009-06-26(m)(m)$363.38M(m)(m)
2008-09-26(m)(m)$394.76M(m)(m)
2007-09-28(m)(m)$368.47M(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.